EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Bowel Disease-Associated Spondyloarthritis

Edit Végh, Rebeka Falcsik, Nóra Bodnár, Szilvia Szamosi iD, Sándor Szántó, Gabriella Szűcs iD, Zoltán Szekanecz iD

Journal of Clinical Medicine · 16.06.2026 · 15 (12) · 4680

DOI: 10.3390/jcm15124680 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.06.2026. Verfasst von Edit Végh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spondyloarthritis associated with inflammatory bowel diseases (IBD-SpA), also known as enteropathic arthritis, is an independent entity belonging to the spondyloarthritis (SpA) group. In recent years, a great amount of new data has been published regarding the pathogenesis and treatment of the disease. In this narrative review we present the main pathogenetic pathways along the gut–joint axis, the genetics of IBD and SpA, the role of environmental factors and that of the microbiome, as well as the main immunopathological processes including immune cells and inflammatory mediators. We cover the clinical picture, the specifics of axial and peripheral SpA-IBD, and briefly discuss the diagnostics. There are common options in the pharmacotherapy of SpA and IBD; however, some drugs that control arthritis (e.g., NSAIDs, IL-17 inhibitors) might not be suitable for the treatment of IBD. Based on the pathogenetic role of the microbiome, it is suggested that pharmacotherapy can be supplemented with non-pharmacological remedies, such as diet including the administration of short-chain fatty acids (SCFAs). Finally, we briefly look at the future that might include rational, even personalized treatment.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseSpA-IBDinflammatory bowel diseasemicrobiomespondyloarthritistargeted therapyulcerative colitis

Autor:innen und Institutionen

  • Department of Rheumatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Department of Sports Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

ORCID-Profile: Szilvia Szamosi, Gabriella Szűcs, Zoltán Szekanecz

Förderung

  • National Research, Development and Innovation Office

Zitieren

APA

Végh, E., Falcsik, R., Bodnár, N., Szamosi, S., Szántó, S., Szűcs, G., & Szekanecz, Z. (2026). Inflammatory Bowel Disease-Associated Spondyloarthritis. Journal of Clinical Medicine, 15(12), 4680. https://doi.org/10.3390/jcm15124680

Vancouver

Végh E, Falcsik R, Bodnár N, Szamosi S, Szántó S, Szűcs G, et al. Inflammatory Bowel Disease-Associated Spondyloarthritis. Journal of Clinical Medicine. 2026;15(12):4680. doi:10.3390/jcm15124680

BibTeX
@article{Vgh2026,
  author = {Végh, Edit and Falcsik, Rebeka and Bodnár, Nóra and Szamosi, Szilvia and Szántó, Sándor and Szűcs, Gabriella and Szekanecz, Zoltán},
  title = {Inflammatory Bowel Disease-Associated Spondyloarthritis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4680},
  doi = {10.3390/jcm15124680}
}
Kostenlos starten →